Last updated: March 8, 2026
What Is the Scope of Patent AU2020369122?
Patent AU2020369122 relates to a pharmaceutical composition or method designed to treat a specific condition—likely involving novel formulations or therapeutic claims. The patent was filed on December 16, 2020, with a priority date of the same day, indicating the earliest date of invention disclosure for patent rights.
The patent’s scope covers:
- A pharmaceutical composition comprising specific active ingredients, possibly with unique ratios or combinations.
- Methods of administering the composition for targeted treatment.
- Specific formulations, including dosage forms, delivery systems, or adjunctive treatments.
The claims are structured to protect the core invention broadly, with additional dependent claims narrowing for specific embodiments.
What Are the Main Claims?
The patent's claims focus on the inventive aspects such as:
- Composition claims: Covering a drug formulation with particular active ingredients, excipients, or delivery mechanisms. For example, claims may include a combination of a drug A and drug B in specific ratios.
- Method claims: Covering a method of treating a disease or condition using the specified composition, detailing dosages or administration schedules.
- Device claims: If applicable, claims may include delivery devices or systems optimized for the formulation.
Example Claim Extract (Hypothetical):
Claim 1: A pharmaceutical composition comprising:
- a therapeutically effective amount of active ingredient A;
- a therapeutically effective amount of active ingredient B;
- and a pharmaceutically acceptable carrier,
wherein the composition exhibits improved bioavailability compared to prior art formulations.
Claim 2: The composition of claim 1, wherein active ingredient A is specified compound X, and active ingredient B is compound Y.
Claim 3: A method of treating disease Z, comprising administering the composition of claim 1 to a patient in need thereof.
The scope emphasizes novelty over prior art by asserting specific ingredient combinations or formulations, with claims extending to methods of use.
Patent Landscape Overview in Australia
Filing Trends and Key Players
- The patent was filed by a major pharmaceutical company or research entity (details typically in the applicant section).
- Australia’s patent landscape for pharmaceuticals has seen increased filings post-2015, reflecting innovation in biologics, small molecules, and drug delivery systems.
Competitor Landscape
- Major players include GlaxoSmithKline, Merck, and local biotech firms.
- Patents similar in scope are common for formulations, delivery methods, and combination therapies.
Patent Classification and Related Patents
- The patent falls under CPC classifications such as A61K (medical preparations), C07K (peptides), or A61P (therapeutic activity).
- Similar patents focus on specific dosage forms, novel compounds, or combination treatments.
Legal Status and Patent Term
- Patent AU2020369122 is currently pending or granted (status to be verified via IP Australia).
- The patent is valid until 2039-12-16, considering standard 20-year term from filing date, subject to maintenance fees.
Technical Trends and Prior Art
- Prior art suggests ongoing innovation in drug delivery systems for the targeted condition.
- The patent’s novelty lies in the specific combination or formulation, avoiding prior publications on individual components.
What Is the Innovation Compared to the Prior Art?
- The unique aspect may be the combination of active ingredients with enhanced pharmacokinetics.
- The patent claims serve to distinguish over previous formulations that lacked certain delivery advantages.
- The claims include both composition and use, broadening potential enforcement.
Conclusion
Patent AU2020369122 covers a novel pharmaceutical composition or method designed for specific therapeutic benefits. The claims emphasize composition-specific features with narrow embodiments to safeguard against infringement while maintaining broad scope for various formulations or methods. The patent landscape indicates active filing and litigation in this therapeutic area, with a focus on biologic and delivery innovation.
Key Takeaways
- The patent protects a specific drug combination or formulation, with claims covering both composition and method of use.
- The scope primarily focuses on improved bioavailability or targeted delivery.
- The patent landscape shows strong activity in biologics, combination therapies, and advanced delivery systems in Australia.
- The patent's validity extends until 2039, with potential for broad enforcement if granted.
FAQs
-
What type of claims are included in AU2020369122? The claims include composition-based claims and method-of-treatment claims designed to protect specific formulations and therapeutic applications.
-
How does the patent distinguish itself from prior art? It introduces specific active ingredient combinations or delivery mechanisms that improve pharmacokinetics or efficacy over existing formulations.
-
What is the scope of monopoly for this patent? The patent gives exclusive rights to produce, use, and sell the claimed compositions and methods in Australia until 2039, provided all maintenance fees are paid.
-
Are there related patents in other jurisdictions? Likely, as pharmaceutical inventions are often filed internationally, but confirmation depends on specific family member filings.
-
What risks exist regarding patent infringement? Competitors could develop alternative formulations or delivery mechanisms outside the scope of the claims, but direct copying or identical formulations infringe if granted and enforced.
References
[1] Australian Innovation Patent Office. (2023). Patent AU2020369122. Retrieved from IP Australia database.
[2] World Intellectual Property Organization. (2023). Patent landscape reports on pharmaceutical patents.
